Record title

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112421

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112421

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

About this item

Full title

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

Publisher

England: BMJ Publishing Group Ltd

Journal title

Annals of the rheumatic diseases, 2014, Vol.73 (8), p.1549-1551

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112421

Language

English

Formats

Publication information

Publisher

More information

Scope and Contents

Contents

Alternative Titles

Full title

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112421

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112421

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item